Table 1 Comparison between inpatients with human seasonal coronaviruses
|  | CoV-229E (N = 33) | CoV-HKU1 (N = 39) | CoV-NL63 (N = 28) | CoV-OC43 (N = 90) | P-value |
|---|---|---|---|---|---|
Age in yearsa | 72 (63–81.5) | 69 (55–82) | 75.5 (56.5–84) | 75.5 (64.5–87.25) | .164 |
Male | 18 (54.5%) | 22 (56.4%) | 12 (42.9%) | 37 (41.1%) | .310 |
White (vs. all other) | 25 (75.8%) | 19 (48.7%) | 19 (67.9%) | 56 (62.2%) | .112 |
Home (vs. SNF) | 22 (66.7%) | 25 (64.1%) | 17 (60.7%) | 57 (63.3%) | .971 |
Two or more comorbidities | 27 (81.8%) | 36 (92.3%) | 25 (89.3%) | 75 (83.3%) | .473 |
Obesity | 12 (36.4%) | 14 (35.9%) | 8 (28.6%) | 25 (27.8%) | .707 |
COPD | 8 (24.2%) | 20 (51.3%)b | 8 (28.6%) | 32 (35.6%) | .085 |
Abnormal CXR | 26 (78.8%) | 28 (71.8%) | 21 (75%) | 65 (72.2%) | .887 |
Severe illness | 26 (78.8%) | 25 (64.1%) | 20 (71.4%) | 58 (64.4%) | .439 |
ICU | 14 (42.4%) | 13 (33.3%) | 14 (50%) | 26 (28.9%) | .167 |
IMV | 9 (27.3%)c | 6 (15.4%) | 2 (7.1%) | 10 (11.1%) | .089 |
Nonsurvivors | 4 (12.1%) | 2 (5.1%) | 5 (17.9%) | 11 (11.2%) | .439 |